OnMarket has a limited allocation. Minimum application size of $10,000. The Company reserves the right to close the offer early.
There are ~59,000 registered charities in Australia, yet +70-80% cannot afford a CRM/SRM solution
Yet these groups need it most to ensure they engage with donors and can get funded in a competitive environment
The charity and Not for Profit (NFP) sectors are becoming increasingly digital and social, yet many they lack the right solution to support their donor engagement and fundraising activities. Current products
SupporterHub provides a fully built central hub for all donor engagement. The platform is tailored for the NFP sector to directly support workflows and operations and provides relationship management tools required to support mass engagement. Crucially, SupporterHub
The offer is a private placement seeking to raise up to $500,000 by issuing convertible notes.
Table 1: Key Offer Stats
Tap 'More Info' to get access to free research, all company releases, and invest instantly for shares.
Koligo Therapeutics Ltd (ASX: KOL) is a US biotechnology company focused on the development and commercialisation of a range of cell therapy, three-dimensional (3D) bioprinted tissue and other regenerative medicine products for serious unmet medical needs. Koligo has successfully commercialised and has commenced selling its first cell therapy transplant product, Kyslecel™, for the treatment of chronic pancreatitis patients, generating $1.6 million in revenue from sales of this product. Koligo is also working on other transformative cell therapies for a range of indications, including type 1 diabetes, and other pancreatic diseases.
Offer closed via OnMarket.
AXS Group Limited (ASX Code: AXS) is an integrated software solution provider to the finance, insurance and funds sector. With over 40 clients in Australia, North America, Europe and Asia they are focussed on helping clients with their digital transformation, reducing time and cutting costs. The Company’s cloud based ARMnet platform currently is used to manage over $100 billion of assets and transactions that are accessible via smart phones, tablets or email from anywhere at any time.
Offer closed early via OnMarket. Payments are now due by 5pm Friday 22 March.
Australian Nutrition & Sports Ltd (ASX: AN1) is focussed on the development, branding and distribution of its own high-quality milk formula, health and wellness products for sale in Australia, China, Hong Kong, with plans to expand into further Asian markets over time. Currently focused on infant and adult milk formula products, protein-based health and wellness nutritional supplements, the company has successfully commercialised a number of products in Hong Kong with distribution through ~350 pharmacies. Expansion into the Chinese market is supported by production agreements with export approved Australian manufacturers.